Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 3137Neoplasms 2472Carcinoma, Non-Small-Cell Lung 1886Prostatic Neoplasms 1635Colorectal Neoplasms 1435Lung Neoplasms 1308Multiple Myeloma 939Neoplasm Metastasis 928Leukemia, Myeloid, Acute 884Pancreatic Neoplasms 856Ovarian Neoplasms 810Melanoma 791Carcinoma, Hepatocellular 742Stomach Neoplasms 648Brain Neoplasms 641Recurrence 640Squamous Cell Carcinoma of Head and Neck 639Head and Neck Neoplasms 612Glioblastoma 573Lymphoma 550Uterine Cervical Neoplasms 545Triple Negative Breast Neoplasms 513Precursor Cell Lymphoblastic Leukemia-Lymphoma 509Carcinoma, Renal Cell 504Hematologic Neoplasms 466Endometrial Neoplasms 466Urinary Bladder Neoplasms 462Colonic Neoplasms 446Lymphoma, Non-Hodgkin 439Sarcoma 436

Interventions

trilaciclib 1durvalumab 1Sodium Chloride 1Probiotics 1Immunotherapy 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × 1 year × Clear all
NCT06773910 2026-04-22

TIGOS-LS

SCRI Development Innovations, LLC

Phase 2 Recruiting
250 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Pharmacosmos A/S

Phase 3 Not yet recruiting
120 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Fudan University

Phase 2 Recruiting
60 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡